78 results
Page 4 of 4
424B5
dvugz1
19 Jan 21
Prospectus supplement for primary offering
4:12pm
8-K
ur1 yg5175
19 Jan 21
Results of Operations and Financial Condition
4:05pm
S-3
EX-1.2
t4dfy1gegu72so
11 Aug 20
Shelf registration
7:58am
S-3
nsy9c0hngajhe
11 Aug 20
Shelf registration
7:58am
10-K
9hgskzudfnvikn8
5 Mar 20
Annual report
4:01pm
8-K
EX-99.1
v1p7v3s8
14 Nov 19
Fulcrum Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
7:10am
10-Q
j2s4547kfwb5
26 Aug 19
Quarterly report
7:43am
424B4
5f9pbie4twuw3m5f8s
18 Jul 19
Prospectus supplement with pricing info
5:19pm
S-1/A
i704ot
8 Jul 19
IPO registration (amended)
6:04am
CORRESP
vp5b p6bn
26 Jun 19
Correspondence with SEC
12:00am
S-1
EX-1.1
emc5b 3vju7sabno7
21 Jun 19
IPO registration
4:26pm
S-1
1xco1s
21 Jun 19
IPO registration
4:26pm
DRS/A
3ecrn8u6
6 Jun 19
Draft registration statement (amended)
12:00am
DRS
tflc0 q6kbcmi5z
1 May 19
Draft registration statement
12:00am